Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

372 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Idiopathic pulmonary fibrosis.
Richeldi L, Collard HR, Jones MG. Richeldi L, et al. Lancet. 2017 May 13;389(10082):1941-1952. doi: 10.1016/S0140-6736(17)30866-8. Epub 2017 Mar 30. Lancet. 2017. PMID: 28365056 Review.
Corticosteroids for idiopathic pulmonary fibrosis.
Richeldi L, Davies HR, Ferrara G, Franco F. Richeldi L, et al. Cochrane Database Syst Rev. 2003;2003(3):CD002880. doi: 10.1002/14651858.CD002880. Cochrane Database Syst Rev. 2003. PMID: 12917934 Free PMC article. Review.
Non-steroid agents for idiopathic pulmonary fibrosis.
Spagnolo P, Del Giovane C, Luppi F, Cerri S, Balduzzi S, Walters EH, D'Amico R, Richeldi L. Spagnolo P, et al. Among authors: richeldi l. Cochrane Database Syst Rev. 2010 Sep 8;(9):CD003134. doi: 10.1002/14651858.CD003134.pub2. Cochrane Database Syst Rev. 2010. PMID: 20824834 Review.
Emerging drugs for idiopathic pulmonary fibrosis.
Selman M, Pardo A, Richeldi L, Cerri S. Selman M, et al. Among authors: richeldi l. Expert Opin Emerg Drugs. 2011 Jun;16(2):341-62. doi: 10.1517/14728214.2011.565049. Epub 2011 Mar 17. Expert Opin Emerg Drugs. 2011. PMID: 21410428 Free article. Review.
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE Jr, Kondoh Y, Myers J, Müller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Schünemann HJ; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. Raghu G, et al. Among authors: richeldi l. Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824. doi: 10.1164/rccm.2009-040GL. Am J Respir Crit Care Med. 2011. PMID: 21471066 Free PMC article.
Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis.
Richeldi L, Costabel U, Selman M, Kim DS, Hansell DM, Nicholson AG, Brown KK, Flaherty KR, Noble PW, Raghu G, Brun M, Gupta A, Juhel N, Klüglich M, du Bois RM. Richeldi L, et al. N Engl J Med. 2011 Sep 22;365(12):1079-87. doi: 10.1056/NEJMoa1103690. N Engl J Med. 2011. PMID: 21992121 Free article. Clinical Trial.
Management of idiopathic pulmonary fibrosis.
Cerri S, Spagnolo P, Luppi F, Richeldi L. Cerri S, et al. Among authors: richeldi l. Clin Chest Med. 2012 Mar;33(1):85-94. doi: 10.1016/j.ccm.2011.11.005. Epub 2011 Dec 28. Clin Chest Med. 2012. PMID: 22365248 Free article. Review.
Interstitial lung diseases. Preface.
King TE Jr, Collard HR, Richeldi L. King TE Jr, et al. Among authors: richeldi l. Clin Chest Med. 2012 Mar;33(1):xiii. doi: 10.1016/j.ccm.2012.01.005. Epub 2012 Feb 2. Clin Chest Med. 2012. PMID: 22365255 No abstract available.
372 results